Revamping Healthcare: A Comprehensive Analysis of China’s 2024 Drug Insurance Directory Adjustments

  • Post author:
  • Post category:

Revamping Healthcare: A Comprehensive Analysis of China's 2024 Drug Insurance Directory Adjustments The 2024 adjustments to China's national healthcare insurance drug directory mark a significant milestone in the ongoing effort…

Continue ReadingRevamping Healthcare: A Comprehensive Analysis of China’s 2024 Drug Insurance Directory Adjustments

Navigating New Regulatory Requirements: Anvisa’s Circular on Medical Device Registrations

Navigating New Regulatory Requirements: Anvisa's Circular on Medical Device Registrations In a significant move to streamline the registration process for medical devices, Anvisa (Agência Nacional de Vigilância Sanitária) has issued…

Continue ReadingNavigating New Regulatory Requirements: Anvisa’s Circular on Medical Device Registrations